




Searching News Database: EnLight
HSMN NewsFeed - 22 Feb 2013
EDAP's Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer
EDAP's Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer
HSMN NewsFeed - 8 Feb 2013
EDAP's Ablatherm-HIFU Demonstrates Long-Term Efficacy and Safety Over Fourteen-Year Period
EDAP's Ablatherm-HIFU Demonstrates Long-Term Efficacy and Safety Over Fourteen-Year Period
HSMN NewsFeed - 30 Jan 2012
EDAP Regains Ablatherm(R)-HIFU Distribution Rights in Canada and Caribbean
EDAP Regains Ablatherm(R)-HIFU Distribution Rights in Canada and Caribbean
HSMN NewsFeed - 20 Jan 2011
EDAP Continues Its Growth Strategy; Enters New Major Market for Lithotripsy
EDAP Continues Its Growth Strategy; Enters New Major Market for Lithotripsy
HSMN NewsFeed - 12 Apr 2010
EDAP Receives European Approval for New Sonolith i-move Lithotripsy Device
EDAP Receives European Approval for New Sonolith i-move Lithotripsy Device
HSMN NewsFeed - 5 Mar 2010
EDAP Presents Ablatherm-HIFU Data in Localized Prostate Cancer at Third Focal Therapy Symposium
EDAP Presents Ablatherm-HIFU Data in Localized Prostate Cancer at Third Focal Therapy Symposium
HSMN NewsFeed - 13 May 2008
EDAP Adds Premiere M.D. Anderson Cancer Center for Phase II/III Ablatherm-HIFU Clinical Trial
EDAP Adds Premiere M.D. Anderson Cancer Center for Phase II/III Ablatherm-HIFU Clinical Trial